Intracranial Self-Stimulation to Evaluate Abuse Potential of Drugs
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554
Olds, J., & Milner, P. (1954) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0058775 · Cited by 3,176 · cited 4×
“Early ICSS studies used standard 50- or 60-Hz sine-wave alternating current delivered by conventional wall sockets, and amplitude was manipulated with a variable potentiometer (Olds and Milner, 1954; Olds, 1958b).”
BackgroundMethodInfluentialCausal Relationship Between Stressful Life Events and the Onset of Major Depression
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.837 · Cited by 2,566
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081 · cited 2×
“…chloride concentrations are usually greater than intracellular concentrations in neurons, activation of GABAA receptors usually causes an influx of negatively charged chloride anions that hyperpolarizes neurons and reduces neuronal excitability (Farrant and Nusser, 2005; Egawa and Fukuda, 2013).”
BackgroundThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
The brain reward circuitry in mood disorders
Russo, S. J., & Nestler, E. J. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3381 · Cited by 1,870 · cited 2×
“Brain reward systems, including the mesolimbic DA system, have been implicated in mood disorders (Nestler and Carlezon, 2006; Russo and Nestler, 2013), and ICSS has been used in preclinical studies aimed at identifying determinants of stress-related depression of positively reinforced be-”
BackgroundDevelopment of a rational scale to assess the harm of drugs of potential misuse
Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60464-4 · Cited by 1,302 · cited 1×
“These two approaches based on expert opinions (Nutt et al., 2007) or on government databases (Fig.”
BackgroundThe neurobiology of anhedonia and other reward-related deficits
Der-Avakian, A., & Markou, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.005 · Cited by 1,130 · cited 1×
“In one family of preclinical procedures aimed at modeling depressive behaviors, animals are repeatedly exposed to stressors, and anhedonia is inferred from resulting depression of behaviors such as feeding and sexual activity (Der-Avakian and Markou, 2012).”
BackgroundCaffeinated energy drinks a growing problem
Reissig, C. J., Strain, E. C., & Griffiths, R. R. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.001 · Cited by 1,026 · cited 1×
“Caffeine is also a common additive to soft drinks and energy drinks, and although caffeine is not scheduled, chronic consumption can meet clinical criteria for dependence (Griffiths and Chausmer, 2000; Reissig et al., 2009).”
BackgroundAddictive Drugs and Brain Stimulation Reward
Wise, R. A. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001535 · Cited by 792
Drug-activation of brain reward pathways
Wise, R. A. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00063-5 · Cited by 684 · cited 3×
“First, drugs could increase sensitivity of the ICSS neural substrate to electrical stimulation (Stellar and Rice, 1989; Wise, 1998).”
BackgroundDramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake
Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., & Kenny, P. J. (2011) · Nature · doi:10.1038/nature09797 · Cited by 663
DeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647 · cited 1×
“…with novel mechanisms of action, biased mu opioid agonists to target selected signaling pathways coupled to mu receptors, selective ligands for GABAA receptor subtypes, and allosteric modulators of NMDA receptors (Mohler, 2012; Burgdorf et al., 2013; DeWire et al., 2013; Fleming et al., 2013).”
BackgroundAddiction circuitry in the human brain
Volkow, N. D., Wang, G.-J., Fowler, J. S., & Tomasi, D. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134625 · Cited by 592
Devine, D. P., Leone, P., Pocock, D., & Wise, R. A. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39324-9 · Cited by 382
Valenzano, K. J., Tafesse, L., Lee, G., Harrison, J. E., Boulet, J. M., Gottshall, S. L., Mark, L., Pearson, M. S., Miller, W., Shan, S., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.008 · Cited by 288 · cited 2×
“…conclusion, we found that the CB2-selective agonist GW405833 [1- (2,3-dichlorobenzoyl)-5-methoxy-2-methyl-3-[2-(4-morpholinyl)ethyl]-1H-indole] (Valenzano et al., 2005) at doses up to 32 mg/kg i.p. had little effect on ICSS in rats responding under a frequency-rate procedure (A. Kwilasz and S.…”
BackgroundSubtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
Conn, P. J., Jones, C. K., & Lindsley, C. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.002 · Cited by 286
Burgdorf, J., Zhang, X.-L., Nicholson, K. L., Balster, R. L., David Leander, J., Stanton, P. K., Gross, A. L., Kroes, R. A., & Moskal, J. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.246 · Cited by 284
Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats
Todtenkopf, M. S., Marcus, J. F., Portoghese, P. S., & Carlezon, W. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1680-y · Cited by 273 · cited 1×
“…U69,593 [Nmethyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1oxaspiro[4.5]dec-8-yl]acetamide], and salvinorin A produce a dose-dependent depression of ICSS (Todtenkopf et al., 2004; Carlezon et al., 2006; Dinieri et al., 2009; Do Carmo et al., 2009; Negus et al., 2010, 2012a; Russell et al., 2013).”
BackgroundInfluentialThe endogenous cannabinoid system and its role in nociceptive behavior
Cravatt, B. F., & Lichtman, A. H. (2004) · Journal of Neurobiology · doi:10.1002/neu.20080 · Cited by 203 · cited 3×
“Cannabinoids constitute a class of natural and synthetic compounds that bind to cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors, which are widely distributed in the brain and periphery (Cravatt and Lichtman, 2004; Karanian and Bahr, 2006; Vlachou and Panagis, 2014).”
BackgroundNeurophysiological analysis of brain-stimulation reward in the monkey
Rolls, E. T., Burton, M. J., & Mora, F. (1980) · Brain Research · doi:10.1016/0006-8993(80)91216-0 · Cited by 193 · cited 1×
“Rats (Olds and Milner, 1954; Wise, 1996), mice (Cazala et al., 1974; Stoker andMarkou, 2011a), nonhuman primates (Rolls et al., 1980), and humans (Bishop et al., 1963; Heath, 1963) will all respond avidly for electrical stimulation of some brain areas.”
BackgroundTranslating Glutamate: From Pathophysiology to Treatment
Javitt, D. C., Schoepp, D., Kalivas, P. W., Volkow, N. D., Zarate, C., Merchant, K., Bear, M. F., Umbricht, D., Hajos, M., Potter, W. Z., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002804 · Cited by 168 · cited 2×
“Glutamate is the primary excitatory neurotransmitter in the mammalian central nervous system, and it binds to an array of ionotropic and metabotropic receptors (Javitt et al., 2011; Osikowicz et al., 2013).”
BackgroundMood disorders: Regulation by metabotropic glutamate receptors
Pilc, A., Chaki, S., Nowak, G., & Witkin, J. M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.021 · Cited by 163
Donahue, R. J., Muschamp, J. W., Russo, S. J., Nestler, E. J., & Carlezon, W. A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.12.014 · Cited by 161 · cited 2×
“…stress, including chronic, intermittent exposure to stressors like restraint and soiled bedding (Moreau et al., 1992, 1994) or social defeat (Donahue et al., 2014), have been reported to depress basal ICSS, and ICSS was also depressed by an olfactory bulbectomy model of depression (Slattery…”
BackgroundSchlaepfer, T. E., Bewernick, B. H., Kayser, S., Hurlemann, R., & Coenen, V. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.28 · Cited by 160 · cited 1×
“These early studies inspired by the discovery of ICSS in rats contributed to technologies and research themes that persist today under the rubric of “deep brain stimulation” (Hariz et al., 2010; Schlaepfer et al., 2014).”
BackgroundCheer, J. F., Heien, M. L. A. V., Garris, P. A., Carelli, R. M., & Wightman, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509607102 · Cited by 143
Intracranial Self-Stimulation in Man
Bishop, M. P., Elder, S. T., & Heath, R. G. (1963) · Science · doi:10.1126/science.140.3565.394 · Cited by 142 · cited 2×
“Rats (Olds and Milner, 1954; Wise, 1996), mice (Cazala et al., 1974; Stoker andMarkou, 2011a), nonhuman primates (Rolls et al., 1980), and humans (Bishop et al., 1963; Heath, 1963) will all respond avidly for electrical stimulation of some brain areas.”
BackgroundFIORINO, D., COURY, A., FIBIGER, H., & PHILLIPS, A. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90109-4 · Cited by 131
Yeomans, J., Forster, G., & Blaha, C. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01038-4 · Cited by 124 · cited 2×
“Details of this linkage remain unclear and could involve direct or indirect trans-synaptic connections via cholinergic intermediaries (Rada et al., 2000; Yeomans et al., 2001).”
BackgroundReinforcing aspects of androgens
Wood, R. I. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.08.012 · Cited by 121 · cited 1×
“In agreement with these ICSS data, testosterone was also reported to function as a significant but weak reinforcer in drug self-administration procedures (Wood, 2004).”
BackgroundGriffiths, R. R., Sannerud, C. A., Ator, N. A., & Brady, J. V. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11429-8 · Cited by 112 · cited 2×
“…et al., 2012); however, numerous drug self-administration studies in nonhuman primates have documented reinforcing effects of zolpidem, and zolpidem is currently classified as a schedule 4 compound by the FDA along with most other benzodiazepines (Griffiths et al., 1992; Licata and Rowlett, 2011).”
BackgroundLeitl, M. D., Onvani, S., Bowers, M. S., Cheng, K., Rice, K. C., Carlezon, W. A., Banks, M. L., & Negus, S. S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.236 · Cited by 87 · cited 2×
“…is linked to depression of mesolimbic dopamine release (Leitl et al., 2014), and it can be blocked by clinically effective analgesics such as mu opioids and nonsteroidal anti-inflammatory drugs (Pereira Do Carmo et al., 2009; Kwilasz and Negus, 2012; Rosenberg et al., 2013; Leitl et al., 2014).”
BackgroundSelf-citationNeisewander, J. L., Peartree, N. A., & Pentkowski, N. S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2853-3 · Cited by 87 · cited 2×
“…illustrate the potential for differential effects of stress as a modulator of abuserelated drug effects in ICSS procedures, but given the prominent role of stress as a risk factor in drug abuse (Neisewander et al., 2012; Volkow et al., 2012), this is a relatively undeveloped theme of research.”
BackgroundLeveraging the cortical cholinergic system to enhance attention
Demeter, E., & Sarter, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.060 · Cited by 75
Negus, S. S., & Rice, K. C. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.127 · Cited by 70 · cited 2×
“…expression of reinforcing effects in preclinical self-administration procedures (Thompson and Schuster, 1964; Yanagita, 1978; Carrera et al., 1999; Negus and Rice, 2009; O’Connor et al., 2011) and expression of abuse-related subjective and reinforcing effects in humans (Lasagna et al., 1955;…”
BackgroundSelf-citationSpiller, K., Xi, Z.-X., Li, X., Ashby, C. R., Callahan, P. M., Tehim, A., & Gardner, E. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.04.006 · Cited by 58
Reynolds, L. M., Engin, E., Tantillo, G., Lau, H. M., Muschamp, J. W., Carlezon, W. A., & Rudolph, U. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.115 · Cited by 49
Engin, E., Bakhurin, K. I., Smith, K. S., Hines, R. M., Reynolds, L. M., Tang, W., Sprengel, R., Moss, S. J., & Rudolph, U. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.41 · Cited by 40
West, C. H. K., Schaefer, G. J., & Michael, R. P. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90010-2 · Cited by 28 · cited 2×
“, under an FR 10 schedule, brain stimulation is delivered after completion of 10 responses) (West et al., 1983; Neill et al., 2002).”
Background
Cited by
Spanagel, R. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/rspanagel · Cited by 221
Altarifi, A. A., David, B., Muchhala, K. H., Blough, B. E., Akbarali, H., & Negus, S. S. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116689257 · Cited by 166
“For example, intracranial selfstimulation (ICSS) is one experimental procedure that has been used for preclinical abuse liability assessment (Negus and Miller, 2014).”
BackgroundMethodSelf-citationComparison of Antidepressant‐Like and Abuse‐Related Effects of Phencyclidine in Rats
Hillhouse, T. M., Porter, J. H., & Negus, S. S. (2014) · Drug Development Research · doi:10.1002/ddr.21228 · Cited by 15
Self-citation
Metadata
- Authors
- Negus, S. S., & Miller, L. L.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 66
- Issue
- 3
- Pages
- 869-917
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2141611982
- Cited by
- 209
- References
- 41
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.